A few words
About us
Using modern technology that meets international standards
we aim to replace imports, treat common diseases with high quality and service, and produce rare pharmaceutical products, improving the health of the people, and meeting consumer needs.
With the implementation of the project
a factory will be established in Mongolia’s pharmaceutical industry that meets the requirements of China’s “Good Manufacturing Practices for Pharmaceuticals”, currently with a capacity to produce 75 million tablets and capsules of 12 types per year, valued at over 30 billion tugriks. We will replace imports and supply the people with quality and safe products at prices 20-25% lower than market prices.
In addition, it has a significant impact on the development of Mongolia’s healthcare sector, especially the pharmaceutical industry. While 70 million USD worth of tablets are imported annually, we have the opportunity to produce 15.1 million USD worth of products that can replace imports domestically.
Social impact
A fully equipped, international-standard pharmaceutical quality control chemical andmicrobiological laboratory has been implemented. We purchased sophisticated equipmentfor pharmaceutical testing from Shimadzu (Japan), a world-leading company, and havefully completed quality assurance, acceptance, and commissioning
I have regularly participated in internship training in Chinese pharmaceutical laboratoriesto learn about equipment operation, principles, and analysis.
By providing mid- and long-term internships to keyhuman resources in thepharmaceutical industry (production managers, quality control managers, qualityassurance managers, laboratory analysts, and engineers) in leading pharmaceuticalcompanies in China, and by providing long-term internships with experts with many yearsof experience in pharmaceutical production, research, and development in Mongolia, ourproject is making a significant contribution to empowering experts in the pharmaceutical industry and training internationally recognized experts.
Livelihood inclusive
With an annual production of 75 million pills of 12 types of drugs that meet China's GMP standards, the price is 20% -25% lower, replacing imports and providing the public with high-quality and affordable medicines.
Import substitution
Annual reduction of 15.1 million US dollars in tablet imports, saving foreign exchange, reducing dependence on overseas drugs, and enhancing industrial autonomy.
Industrial upgrading
filling the gap in modern production capacity of Mongolian pharmaceutical companies, driving technological and management upgrades, attracting resources, and promoting the improvement of the entire industry chain.